Cost-effectiveness Analysis of Four Different Drugs for Benign Prostatic Hypertrophy / 中国药房

ABSTRACT

AIM:To evaluate the economic effectiveness of different therapeutic schemes for benign prostatic hypertrophy METHODS:175 patients with benign prostatic hypertrophy were divided into 4 groupsA,B,C and D They received different drugs,Atamsulosin(34),Bprostat(45),Ctedenan(46) and Dqiangliexin(50) RESULTS:The costs of A,B,C,D schemes were RMB 492 80,499 52,526 40 and 664 16 yuans,respectively,and the effective ratios were 85 3%,82 2%,80 4% and 80 0%,respectively CONCLUSION:According to the evaluation with pharmacoeconomic cost-effectiveness analysis,A is the best scheme